Bioxytran (BIXT) EBITDA Margin Growth (5y) (2015 - 2018)
Bioxytran (BIXT) EBITDA Margin Growth (5y) (2015 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 63,730.00 |
| Mar 31, 2018 | 84,622.00 |
| Dec 31, 2017 | 84,971.00 |
| Sep 30, 2017 | 494,454.00 |
| Jun 30, 2017 | -9,493.00 |
| Mar 31, 2017 | -48,527.00 |
| Dec 31, 2016 | 1.13 Mn |
| Sep 30, 2016 | 242,762.00 |
| Jun 30, 2016 | 15,439.00 |
| Mar 31, 2016 | 1.60 Mn |
| Dec 31, 2015 | 126,910.00 |
| Sep 30, 2015 | 387,257.00 |